GRI Bio, Inc. Common Stock (GRI) is a publicly traded Healthcare sector company. As of May 21, 2026, GRI trades at $2.23 with a market cap of $3.09M and a P/E ratio of -0.02. GRI moved -0.45% today. Year to date, GRI is -74.50%; over the trailing twelve months it is -94.58%. Its 52-week range spans $1.97 to $852.04. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces GRI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
GRI Bio, Inc. Common Stock (GRI) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. GRI moved -0.45% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $2.23 |
| Market Cap | $3.09M |
| P/E Ratio | -0.02 |
| EPS | $-121.80 |
| Dividend Yield | 0.00% |
| 52-Week High | $852.04 |
| 52-Week Low | $1.97 |
| Volume | 43 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-11.96M |
| Gross Margin | 0.00% |
2 analysts cover GRI: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.